Heme Oxygenase in Physiology and Pathology

A special issue of Antioxidants (ISSN 2076-3921). This special issue belongs to the section "Health Outcomes of Antioxidants and Oxidative Stress".

Deadline for manuscript submissions: closed (15 February 2022) | Viewed by 12440

Special Issue Editor


E-Mail Website
Guest Editor
Department for Biomedical Sciences, Institute for Medical Biochemistry, University of Veterinary Medicine, 1210 Vienna, Austria
Interests: heme oxygenase in cell and organ dysfunction; heme oxygenase and biliverdin reductase activity; ferroptosis; oxidative stress response
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Heme oxygenase (HO) catalyzes the rate-limiting step of heme degradation, yielding carbon monoxide (CO), ferrous iron (Fe2+), and biliverdin. In mammalian tissues, the HO reaction product biliverdin is further reduced to bilirubin by biliverdin reductase. The mechanism of heme cleavage is evolutionarily conserved and essential for various cellular processes in nearly all living organisms. In plants, enzymatic heme degradation serves for the synthesis of chromophores of photoreceptors, while many microorganisms and animals use HO for iron acquisition from heme. Mammalian heme oxygenase exists in three isoforms, of which only two are catalytically active—the inducible isoform HO-1 and the constitutively expressed isoform HO-2. Various pathophysiological stimuli, such as heme, oxidative stress, hypoxia, and inflammation, induce HO-1 via multiple response elements in the HO-1 promoter region. Both enzymes contribute to the overall HO activity, which is not only required for iron redistribution within the organism, and to maintain homeostasis of heme-proteins. Most importantly, HO activity provides cytoprotection, predominantly by two synergistic effects—the removal of heme, which exerts pro-oxidative effects when in excess, and the generation of the HO products, CO and biliverdin/bilirubin, which possess potent anti-oxidative, anti-apoptotic, and anti-inflammatory properties. Further, both metabolites play important roles as signaling molecules.

Moreover, recent findings show that HO may exert functions not related to its enzymatic activity, such as the formation of protein-protein interactions and involvement in signaling events. Although anchored to the membrane of the endoplasmic reticulum, certain pathophysiological conditions may lead to translocation of a truncated HO isoform to the nuclear compartment, where it can activate stress-associated nuclear transcription factors and DNA repair mechanisms.

However, dysregulated HO may unfold unfavorable effects and contribute to tissue injury, neurodegeneration, and carcinogenesis. Therefore, therapeutic approaches targeting the HO system are promising strategies to restore homeostasis and to support tissue repair. However, many questions related to the different roles of HO isoforms and to their newly discovered functions in physiology and pathology still remain open.

This Special Issue invites methodological approaches, research papers, or reviews that present new findings or concepts on the roles and functions of HO enzymes and their reaction products in animal and plant physiology. Suitable topics include (but are not limited to): structure, function, and regulation of HO in different species; the role of HO and its products in physiological and pathological conditions modulating cell metabolism, signaling, and cell cycle; epigenetic regulation; repair function; and the control of oxidative stress. 

Dr. J. Catharina Duvigneau
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antioxidants is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (4 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review, Other

25 pages, 6143 KiB  
Article
Limited Heme Oxygenase Contribution to Modulating the Severity of Salmonella enterica serovar Typhimurium Infection
by Valentina P. Sebastián, Daniela Moreno-Tapia, Felipe Melo-González, María P. Hernández-Cáceres, Geraldyne A. Salazar, Catalina Pardo-Roa, Mónica A. Farías, Omar P. Vallejos, Bárbara M. Schultz, Eugenia Morselli, Manuel M. Álvarez-Lobos, Pablo A. González, Alexis M. Kalergis and Susan M. Bueno
Antioxidants 2022, 11(6), 1040; https://doi.org/10.3390/antiox11061040 - 24 May 2022
Cited by 4 | Viewed by 2697
Abstract
An important virulence trait of Salmonella enterica serovar Typhimurium (S. Typhimurium) is the ability to avoid the host immune response, generating systemic and persistent infections. Host cells play a crucial role in bacterial clearance by expressing the enzyme heme oxygenase 1 (Hmox1), [...] Read more.
An important virulence trait of Salmonella enterica serovar Typhimurium (S. Typhimurium) is the ability to avoid the host immune response, generating systemic and persistent infections. Host cells play a crucial role in bacterial clearance by expressing the enzyme heme oxygenase 1 (Hmox1), which catalyzes the degradation of heme groups into Fe2+, biliverdin, and carbon monoxide (CO). The role of Hmox1 activity during S. Typhimurium infection is not clear and previous studies have shown contradictory results. We evaluated the effect of pharmacologic modulation of Hmox1 in a mouse model of acute and persistent S. Typhimurium infection by administering the Hmox1 activity inductor cobalt protoporphyrin-IX (CoPP) or inhibitor tin protoporphyrin-IX (SnPP) before infection. To evaluate the molecular mechanism involved, we measured the colocalization of S. Typhimurium and autophagosome and lysosomal markers in macrophages. Administering CoPP reduced the bacterial burden in organs of mice 5 days post-infection, while SnPP-treated mice showed bacterial loads similar to vehicle-treated mice. Furthermore, CoPP reduced bacterial loads when administered after infection in macrophages in vitro and in a persistent infection model of S. Typhimurium in vivo, while tin protoporphyrin-IX (SnPP) treatment resulted in a bacterial burden similar to vehicle-treated controls. However, we did not observe significant differences in co-localization of green fluorescent protein (GFP)-labeled S. Typhimurium with the autophagic vesicles marker microtubule-associated protein 1A/1B-light chain 3 (LC3) and the lysosomal marker lysosomal-associated membrane protein 1 (LAMP-1) in macrophages treated with CoPP. Our results suggest that CoPP can enhance antimicrobial activity in response to Salmonella infection, reducing bacterial dissemination and persistence in mice, in a CO and autophagy- independent manner. Full article
(This article belongs to the Special Issue Heme Oxygenase in Physiology and Pathology)
Show Figures

Figure 1

Review

Jump to: Research, Other

17 pages, 1649 KiB  
Review
Roles of Heme Oxygenase-1 in Neuroinflammation and Brain Disorders
by Yi-Hsuan Wu and Hsi-Lung Hsieh
Antioxidants 2022, 11(5), 923; https://doi.org/10.3390/antiox11050923 - 8 May 2022
Cited by 32 | Viewed by 2631
Abstract
The heme oxygenase (HO) system is believed to be a crucial mechanism for the nervous system under stress conditions. HO degrades heme to carbon monoxide, iron, and biliverdin. These heme degradation products are involved in modulating cellular redox homeostasis. The first identified isoform [...] Read more.
The heme oxygenase (HO) system is believed to be a crucial mechanism for the nervous system under stress conditions. HO degrades heme to carbon monoxide, iron, and biliverdin. These heme degradation products are involved in modulating cellular redox homeostasis. The first identified isoform of the HO system, HO-1, is an inducible protein that is highly expressed in peripheral organs and barely detectable in the brain under normal conditions, whereas HO-2 is a constitutive protein that is highly expressed in the brain. Several lines of evidence indicate that HO-1 dysregulation is associated with brain inflammation and neurodegeneration, including Parkinson’s and Alzheimer’s diseases. In this review, we summarize the essential roles that the HO system plays in ensuring brain health and the molecular mechanism through which HO-1 dysfunction leads to neurodegenerative diseases and disruption of nervous system homeostasis. We also provide a summary of the herbal medicines involved in the regulation of HO-1 expression and explore the current situation regarding herbal remedies and brain disorders. Full article
(This article belongs to the Special Issue Heme Oxygenase in Physiology and Pathology)
Show Figures

Figure 1

19 pages, 1990 KiB  
Review
Crosstalk between Heme Oxygenase-1 and Iron Metabolism in Macrophages: Implications for the Modulation of Inflammation and Immunity
by Joseana de Oliveira, Marina B. Denadai and Diego L. Costa
Antioxidants 2022, 11(5), 861; https://doi.org/10.3390/antiox11050861 - 27 Apr 2022
Cited by 14 | Viewed by 3605
Abstract
Heme oxygenase-1 (HO-1) is an enzyme that catalyzes the degradation of heme, releasing equimolar amounts of carbon monoxide (CO), biliverdin (BV), and iron. The anti-inflammatory and antioxidant properties of HO-1 activity are conferred in part by the release of CO and BV and [...] Read more.
Heme oxygenase-1 (HO-1) is an enzyme that catalyzes the degradation of heme, releasing equimolar amounts of carbon monoxide (CO), biliverdin (BV), and iron. The anti-inflammatory and antioxidant properties of HO-1 activity are conferred in part by the release of CO and BV and are extensively characterized. However, iron constitutes an important product of HO-1 activity involved in the regulation of several cellular biological processes. The macrophage-mediated recycling of heme molecules, in particular those contained in hemoglobin, constitutes the major mechanism through which living organisms acquire iron. This process is finely regulated by the activities of HO-1 and of the iron exporter protein ferroportin. The expression of both proteins can be induced or suppressed in response to pro- and anti-inflammatory stimuli in macrophages from different tissues, which alters the intracellular iron concentrations of these cells. As we discuss in this review article, changes in intracellular iron levels play important roles in the regulation of cellular oxidation reactions as well as in the transcriptional and translational regulation of the expression of proteins related to inflammation and immune responses, and therefore, iron metabolism represents a potential target for the development of novel therapeutic strategies focused on the modulation of immunity and inflammation. Full article
(This article belongs to the Special Issue Heme Oxygenase in Physiology and Pathology)
Show Figures

Figure 1

Other

Jump to: Research, Review

9 pages, 1617 KiB  
Viewpoint
Therapeutic Potential of Inducible Endogenous Cytoprotective Heme Oxygenase-1 in Mitigating SARS-CoV-2 Infection and Associated Inflammation
by Subhash Dhawan
Antioxidants 2022, 11(4), 662; https://doi.org/10.3390/antiox11040662 - 30 Mar 2022
Cited by 3 | Viewed by 2307
Abstract
The inducible cytoprotective enzyme heme oxygenase-1 (HO-1) has gained significant recognition in recent years for mediating strong cellular resistance to a broad range of viral infections, regardless of the type of viruses, viral strains, or mutants. HO-1 is not a typical antiviral agent [...] Read more.
The inducible cytoprotective enzyme heme oxygenase-1 (HO-1) has gained significant recognition in recent years for mediating strong cellular resistance to a broad range of viral infections, regardless of the type of viruses, viral strains, or mutants. HO-1 is not a typical antiviral agent that targets any particular pathogen. It is a “viral tropism independent” endogenous host defense factor that upon induction provides general cellular protection against pathogens. By virtue of HO-1 being widely distributed intracellular enzyme in virtually every cell, this unique host factor presents a novel class of generic host defense system against a variety of viral infections. This Viewpoint proposes pharmacological evaluation of the HO-1-dependent cellular resistance for its potential in mitigating infections by deadly viruses, including the current severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), its variants, and mutants. HO-1-dependent cellular resistance against SARS-CoV-2 can complement current medical modalities for much effective control of the COVID-19 pandemic, especially with constantly emerging new viral variants and limited therapeutic options to treat SARS-CoV-2 infection and associated severe health consequences. Full article
(This article belongs to the Special Issue Heme Oxygenase in Physiology and Pathology)
Show Figures

Graphical abstract

Back to TopTop